BIOS Fund I, LP

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Fort Worth, TX
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
Bios Fund I, LP By: Bios Equity Partners, LP, its general partner By: Cavu Management, LP, its general partner By: Cavu Advisors, LLC, its general partner By: /s/ John Fucci, as attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for BIOS Fund I, LP

Form 4 holding Director, 10%+ Owner

ACTUATE THERAPEUTICS, INC.

Security class
Warrant (Right to Buy)
Shares / value
824,012
Estimated value
Report date
28 Oct 2026
Price
Ownership
Directly held by Bios Fund III QP, LP
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

ACTUATE THERAPEUTICS, INC.

Security class
Warrant (Right to Buy)
Shares / value
682,885
Estimated value
Report date
28 Oct 2026
Price
Ownership
Directly held by Bios Actuate Co-Invest II, LP
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

ACTUATE THERAPEUTICS, INC.

Security class
Warrant (Right to Buy)
Shares / value
368,304
Estimated value
Report date
28 Oct 2026
Price
Ownership
Directly held by Bios Clinical Opportunity Fund, LP
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

ACTUATE THERAPEUTICS, INC.

Security class
Warrant (Right to Buy)
Shares / value
269,342
Estimated value
Report date
28 Oct 2026
Price
Ownership
Directly held by Bios Fund II QP, LP
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

ACTUATE THERAPEUTICS, INC.

Security class
Warrant (Right to Buy)
Shares / value
194,984
Estimated value
Report date
28 Oct 2026
Price
Ownership
Directly held by Bios Actuate Co-Invest III, LP
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

ACTUATE THERAPEUTICS, INC.

Security class
Warrant (Right to Buy)
Shares / value
133,073
Estimated value
Report date
28 Oct 2026
Price
Ownership
Directly held by Bios Fund III NT, LP
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

ACTUATE THERAPEUTICS, INC.

Security class
Warrant (Right to Buy)
Shares / value
126,162
Estimated value
Report date
28 Oct 2026
Price
Ownership
Directly held by Bios Fund III, LP
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

ACTUATE THERAPEUTICS, INC.

Security class
Warrant (Right to Buy)
Shares / value
87,743
Estimated value
Report date
28 Oct 2026
Price
Ownership
Directly held by Bios Actuate Co-Invest I, LP
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

ACTUATE THERAPEUTICS, INC.

Security class
Warrant (Right to Buy)
Shares / value
82,454
Estimated value
Report date
28 Oct 2026
Price
Ownership
Directly held by Bios Fund II, LP
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

ACTUATE THERAPEUTICS, INC.

Security class
Warrant (Right to Buy)
Shares / value
82,018
Estimated value
Report date
28 Oct 2026
Price
Ownership
Directly held by Bios Fund I, LP
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

ACTUATE THERAPEUTICS, INC.

Security class
Warrant (Right to Buy)
Shares / value
64,995
Estimated value
Report date
28 Oct 2026
Price
Ownership
Directly held by Bios 2024 Co-Invest, LP
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

ACTUATE THERAPEUTICS, INC.

Security class
Warrant (Right to Buy)
Shares / value
47,972
Estimated value
Report date
28 Oct 2026
Price
Ownership
Directly held by Bios Fund I QP, LP
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

ACTUATE THERAPEUTICS, INC.

Security class
Warrant (Right to Buy)
Shares / value
36,056
Estimated value
Report date
28 Oct 2026
Price
Ownership
Directly held by Bios Fund II NT, LP
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by BIOS Fund I, LP

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .